Independent fund Beresford Ventures operates as a ledger fund with no external assets under management, no carry, and limited outside investors. This suggests a flexible, founder-aligned sales approach focusing on bespoke partnerships and potential co-investment opportunities with like-minded angels or small seed funds.

Early stage focus The firm primarily writes small pre-seed checks and is stage agnostic but skewed toward early-stage investing. This creates a selling point for emerging technology vendors, startup services, and platform tools that cater to seed-stage management, fundraising readiness, and rapid go-to-market acceleration.

Global reach With 135 portfolio companies across the US, Canada, Latin America, the Middle East, and Africa, Beresford maintains a diversified, cross-border deal flow. Opportunities exist to provide region-specific market intelligence, compliance tooling, localization services, and international go-to-market support for portfolio companies expanding abroad.

Recent participation The firm recently invested $2M in Hyivy Health Inc., indicating active deal execution and willingness to participate in seed rounds alongside other investors. This signals openness to partnerships with health tech, impact-focused, and tech-enabled healthcare startups seeking seed-stage growth capital.

Operational toolkit Utilizes a lean tech stack and modern digital presence, suggesting readiness to adopt services that support portfolio management, deal sourcing, and back-office efficiency. Potential upsell includes fintech, CRM, analytics, and lightweight collaboration tools tailored for small fund operations and ledger investing.